ESC 365 - State of the Art: TAVI indications and adoption: a dynamic field

ESC Premium Access

State of the Art: TAVI indications and adoption: a dynamic field

Session: TAVI: a new standard for aortic valve replacement?

Topic: Aortic valve disease

Speaker: Professor B. Prendergast (London, GB)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

21 presentations

9 followers

4 more presentations in this session

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Speaker: Doctor B. Alushi (Munich, DE)

TAVI complications: incidence, trends and management.

Speaker: Professor A. Chieffo (Milan, IT)

Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Professor B. Prendergast, Professor E. Durand, Doctor U. Fischer-Rasokat, Doctor B. Alushi, Professor A. Chieffo

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources